RT Journal Article
SR Electronic
T1 Air Pollution and Lipometabolic Disturbance: A Systematic Review and Meta-Analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.19.20106849
DO 10.1101/2020.05.19.20106849
A1 Chen, Haohao
A1 Shi, Liuhua
A1 Rosenberg, Andrew
A1 Zhu, Ye
A1 Tao, Lixin
A1 Sun, Zhiwei
A1 Wang, Ji
YR 2020
UL http://medrxiv.org/content/early/2020/05/26/2020.05.19.20106849.abstract
AB Background Growing evidence suggests that long-term exposure to air pollutants is associated with cardiovascular morbidity, including lipometabolic disturbance.Objectives To explore the chronic effects of air pollutants on lipametabolic disturbance via detectable lipoprotein parameters.Methods Seven online databases were searched to conduct a meta-analysis of epidemiological studies examining the relationship between air pollution and lipid parameter levels. Subgroup analysis was additionally carried out for each air pollutant studied.Results A total of 2,274 records were retrieved, resulting in 10 studies included in the final quantitative meta-analysis, comprising seven studies in Europe and the United States and three studies in mainland China. Using a random-effect model, the results showed that for each 10 μg/m3 increase in PM2.5, TC, LDL-C, and HDL-C levels and metabolic syndrome (MetS) incidence increased by 3.31% (95% CI: 2.29%, 8.91%), 2.34% (95% CI: 1.30%, 3.39%), −1.57% (95% CI: −1.85%, −1.28%), and 4.33% (95% CI: 2.69%, 5.98%), respectively; for each 10 μg/m3 increase in PM10, TG, HDL-C, and LDL-C levels increased by 5.27% (95% CI: 2.03%, 8.50%), −0.24% (95% CI: −0.95%, −0.47%), and 0.45% (95% CI: −0.57%, 1.47%), respectively; for each 10 μg/m3 increase in NO2, TG and HDL-C levels increased by 4.18% (95% CI: 1.12%, 7.23%) and −0.51% (95% CI: −2.61%, 1.58%), respectively. No significant associations were detected for combinations of air pollutants on lipometabolic disturbance.Conclusion Increased air pollutant exposure was significantly associated with changes in blood lipid parameter levels, which can be an indicator of the body’s lipometabolic disturbance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Natural Science Foundation of China (81872649), National Key R&D Program of China (2017YFC0211600), Scientific Research Project of Beijing Educational Committee (KM201910025023), and HERCULES Exposome Research Centre (P30ES019776).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study was conducted using standard methods which follow the Preferred Reporting Items for Systematic Review and Meta-Analysis (PISMA)(J et al., 2020; "Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation," 2016). Seven electronic databases, including China National Knowledge Infrastructure (CNKI), Wanfang, Vip, SinoMed, Pubmed, EMBASE, and the Cochrane Library, were searched for peer-reviewed articles published from 2000 to January 28, 2020. Keywords searched included: ("Air Pollution" OR "Pollution, Air" OR "Air Quality" OR "Ultrafine Fibers" OR "Airborne Particulate Matter" OR "Particulate Matter, Airborne" OR "Air Pollutants, Particulate" OR "Particulate Air Pollutants" OR "Ambient Particulate Matter" OR "Particulate Matter, Ambient" OR "Ultrafine Particulate Matter" OR "Particulate Matter, Ultrafine" OR "Ultrafine Particles" OR "Particles, Ultrafine") AND ("Cardiovascular Disease" OR "Disease, Cardiovascular" OR "Diseases, Cardiovascular" OR "HDL" OR "LDL" OR "cholesterol" OR " cholesterin" OR "cholesteric" OR "TC" OR "TG" OR "dyslipidaemia" OR "HDL-C" OR "LDL-C") AND ("Cohort" OR "Cross-sectional" OR "Case control" OR "Case-control" OR "Epidemiology OR "Epidemiological"). Additionally, references of included literature and one previously published systematic review were manually retrieved. https://pubmed.ncbi.nlm.nih.gov/27218271/ https://doi.org/10.1016/j.envint.2018.07.016 https://doi.org/10.1016/j.scitotenv.2018.11.149 https://doi.org/10.3390/ijerph15040631 https://doi.org/10.1093/aje/kww157 https://doi.org/10.1016/j.envint.2015.09.021 https://www.ncbi.nlm.nih.gov/pubmed/20853625 https://doi.org/10.1097/ede.0000000000000426 https://doi.org/10.1016/j.ijheh.2019.01.010 https://doi.org/10.1016/j.envint.2020.105459